ARS Pharmaceuticals, Inc. (SPRY) Stock Chart - Revenue & Earnings | Quarter Chart

📊 Income Statement

Revenue by Product

Revenue by Geography

Revenue, Gross Profit, Operating and Net Income

RevenueGross ProfitOperating IncomeNet Income
050M100M150M200M250M300M350M400MQ4 2024Q1 2025Q2 2025Q3 2025Q4 2025

Margin (%)

Gross MarginOperating MarginNet Income Margin
03875112150188225262300Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025

Operating Expenses

Research And Development ExpensesSelling General And Administrative ExpensesOther Expenses
011M22M34M45M56M68M79M90MQ4 2024Q1 2025Q2 2025Q3 2025Q4 2025

EBITDA

EBITDA
-60M-45M-30M-15M015M30M45M60MQ4 2024Q1 2025Q2 2025Q3 2025Q4 2025

EPS

EPSEPS Diluted
000111222Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025

Revenue Variation (%)

Revenue Variation
-2004501K2K2K3K4K4K5KQ4 2024Q1 2025Q2 2025Q3 2025Q4 2025

Income Variation (%)

Gross Profit VariationOperating Income Variation
06251K2K2K3K4K4K5KQ4 2024Q1 2025Q2 2025Q3 2025Q4 2025

Revenue YoY Variation (%)

Revenue YoY Variation
-804309401K2K2K3K3K4KQ2 2025Q3 2025Q4 2025

Income YoY Variation (%)

Gross Profit YoY VariationOperating Income YoY Variation
03757501K2K2K2K3K3KQ4 2024Q1 2025Q2 2025Q3 2025Q4 2025

Price-to-Earning Ratio

P/E Ratio
-20-17-14-10-7-4-036Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025

Income Breakdown

Operating IncomeInterest IncomeTotal Other Income Expenses NetNet Income
025M50M75M100M125M150M175M200MQ4 2024Q1 2025Q2 2025Q3 2025Q4 2025

Per Share Metrics

Revenue Per ShareNet Income Per ShareOperating Cash Flow Per Share
001122233Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025

Expense Ratios

Research And Ddevelopement To RevenueCapex To RevenueStock Based Compensation To Revenue
000111222Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025
💰 Cash Flow Statement

Operating Cash Flow

Operating Cash FlowCapital ExpenditureFree Cash Flow
012M25M38M50M62M75M88M100MQ4 2024Q1 2025Q2 2025Q3 2025Q4 2025

Free Cash Flow

Cash At End Of Period
09M18M26M35M44M52M61M70MQ4 2024Q1 2025Q2 2025Q3 2025Q4 2025

Cash Flow to Debt Ratio

Net Cash Provided By Operating ActivitiesNet Cash Used Provided By Financing Activities
025M50M75M100M125M150M175M200MQ4 2024Q1 2025Q2 2025Q3 2025Q4 2025
🏦 Balance Sheet
📈 Key Metrics